In memoriam: Melvin Simpson
Melvin Simpson, founder of the biochemistry department at Stony Brook University and a member of the American Society for Biochemistry and Molecular Biology since 1955, died January 31, 2022, the society learned recently. He was 100 years old.

Simpson was born July 15, 1921. He earned his Ph.D. in 1949 from the University of California at Berkeley for studies of protein biosynthesis in the laboratory of Harold Tarver and began his independent career as a professor at Yale before moving to Dartmouth where he was an American Cancer Society Professor.
In 1967, Simpson joined the faculty of Stony Brook University to start a section in biochemistry within the biology department. Two years later, biochemistry became a separate department with Simpson as the founding chair. He worked to recruit faculty as well as establish a positive inspiring environment. “He always had a smile on his face … he wanted everyone to be happy,” Norm Arnheim recalled in a Stony Brook memorial article.
Protein synthesis was the focus of Simpson’s early scientific career; he pioneered a method to track synthesis using radioactive methionine. Later, his interests expanded to include DNA, in particular mitochondrial DNA synthesis and metabolism. His studies included work on a mitochondrial topoisomerase and mitochondrial DNA evolution. He also studied the mechanism of nucleoside analog AZT, which was being tested as an AIDS antiviral at the time.
Simpson served in the US Navy during World War II. He maintained a love of boats and sailing his whole life, often sharing stories of places he visited. His wide-ranging interests beyond scientific research included archeology, a subject in which he took classes at Stony Brook while a professor.
Simpson’s colleagues and former students remember him as someone who treated everyone with respect and kindness; they write that he was a good mentor who asked critical questions while also supporting his mentees and colleagues with a helping hand both within and outside of the lab.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.